141 related articles for article (PubMed ID: 5410907)
21. [Value of the clinical use of proscillaridin A].
Ratti G; Rocca F; Savastano A
Clin Ter; 1966 Sep; 38(5):413-24. PubMed ID: 5993561
[No Abstract] [Full Text] [Related]
22. [Practical problems of the use of cardiac glycosides].
Naumov VG; Tsibekmakher TD; Mareev VIu
Ter Arkh; 1978; 50(12):125-32. PubMed ID: 741370
[No Abstract] [Full Text] [Related]
23. [Principles and directives for practical treatment with cardiac glycosides].
Dörffel EF
Z Arztl Fortbild (Jena); 1971 Mar; 65(5):237-44. PubMed ID: 4997296
[No Abstract] [Full Text] [Related]
24. [Certain problems of emergency therapy of the disorders of cardiac rhythm].
Nedostup AV
Ter Arkh; 1973; 45(2):87-95. PubMed ID: 4768362
[No Abstract] [Full Text] [Related]
25. [Functional disorders of the cardiovascular system in patients with severe thyrotoxicosis and their treatment in the early postoperative period].
Neĭmark MI
Klin Med (Mosk); 1977 May; 55(5):57-64. PubMed ID: 69050
[No Abstract] [Full Text] [Related]
26. [Effect of various cardiac glycosides on central hemodynamics after operations on the abdominal organs].
Shanin SS; Zheludov EP
Vestn Khir Im I I Grek; 1985 Nov; 135(11):107-9. PubMed ID: 4095850
[TBL] [Abstract][Full Text] [Related]
27. [Problems of postoperative digitalis therapy].
Kreuzer H; Bircks W
Thoraxchir Vask Chir; 1969 Dec; 17(6):455-9. PubMed ID: 5312712
[No Abstract] [Full Text] [Related]
28. Value of inderal in long-term treatment of cardiac arrhythmias.
Chlebus H; Raczyński J
Pol Med J; 1972; 11(1):1-10. PubMed ID: 4114356
[No Abstract] [Full Text] [Related]
29. [Cardiac glycosides: indications, selection and dosage].
Kuhlmann J
Med Klin; 1982 Jan; 77(3):18-22. PubMed ID: 7057727
[No Abstract] [Full Text] [Related]
30. [The therapy of cardiac insufficiency using Theo-Alvonal].
Kettermann W
Munch Med Wochenschr; 1968 Jan; 110(4):228-32. PubMed ID: 5695033
[No Abstract] [Full Text] [Related]
31. Effects of digoxin and digitoxin on ventricular function in normal dogs and dogs with heart failure.
Hamlin RL; Dutta S; Smith CR
Am J Vet Res; 1971 Sep; 32(9):1391-8. PubMed ID: 5094523
[No Abstract] [Full Text] [Related]
32. [Certain problems of pharmacodynamics, pharmacokinetics and the use of cardiac glycosides].
Kukes VG; Volkov RIu
Kardiologiia; 1977 Sep; 17(9):135-42. PubMed ID: 144820
[No Abstract] [Full Text] [Related]
33. Proceedings: On antifibrillatory properties of cardiac glycosides.
Brassel G; Lange-Asschenfeldt H
Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R12. PubMed ID: 4276528
[No Abstract] [Full Text] [Related]
34. [Indications, contra-indications and dosage of cardiac glycosides controlled by plasma levels in the aged].
Hötter GJ
Z Gerontol; 1987; 20(1):8-12. PubMed ID: 3577317
[TBL] [Abstract][Full Text] [Related]
35. [Treatment of cardiac rhythm disorders].
Sumarokov AV; Mikhaĭlov AA
Ter Arkh; 1975; 47(5):67-74. PubMed ID: 51516
[No Abstract] [Full Text] [Related]
36. Treatment of chronic right-heart lesions. Proscillaridin for cor pulmonale and the senile heart.
Neumann H
Geriatrics; 1966 Jun; 21(6):180-5. PubMed ID: 5949184
[No Abstract] [Full Text] [Related]
37. [The attack-like heart gallop].
Donat K
Internist (Berl); 1968 Jul; 9(7):297-305. PubMed ID: 4178138
[No Abstract] [Full Text] [Related]
38. [Clinical studies with a new cardiac glycoside proscillaridine A (Sandoscill)].
Hansel J
Med Klin; 1968 Jun; 63(23):919-22. PubMed ID: 4875202
[No Abstract] [Full Text] [Related]
39. Treatment of supraventricular tachyarrhythmias.
Orlando J; Aronow WS
Arch Intern Med; 1979 Nov; 139(11):1298-301. PubMed ID: 508027
[No Abstract] [Full Text] [Related]
40. [Effect of cardiac glycosides on the statistical distribution of R-R ventricular distances in complete arrhythmia].
Pedich W; Antoniuk Z
Pol Arch Med Wewn; 1967; 39(4):449-57. PubMed ID: 5582668
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
